REPETITIVE WEEKLY CYCLES OF RECOMBINANT HUMAN INTERLEUKIN-2 - RESPONSES OF RENAL-CARCINOMA WITH ACCEPTABLE TOXICITY

被引:160
作者
SOSMAN, JA
KOHLER, PC
HANK, J
MOORE, KH
BECHHOFER, R
STORER, B
SONDEL, PM
机构
[1] UNIV WISCONSIN,CTR CLIN SCI,600 HIGHLAND AVE,K4-448,MADISON,WI 53792
[2] UNIV WISCONSIN,DEPT HUMAN ONCOL,MADISON,WI 53792
[3] UNIV WISCONSIN,DEPT STAT,MADISON,WI 53792
[4] UNIV WISCONSIN,DEPT PEDIAT,MADISON,WI 53792
[5] UNIV WISCONSIN,DEPT GENET,MADISON,WI 53792
[6] MADISON GEN HOSP,DEPT MED,MADISON,WI 53715
关键词
D O I
10.1093/jnci/80.1.60
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:60 / 63
页数:4
相关论文
共 29 条
[1]   EFFECTS OF INTERLEUKIN-2 ON RENAL-FUNCTION IN PATIENTS RECEIVING IMMUNOTHERAPY FOR ADVANCED CANCER [J].
BELLDEGRUN, A ;
WEBB, DE ;
AUSTIN, HA ;
STEINBERG, SM ;
WHITE, DE ;
LINEHAN, WM ;
ROSENBERG, SA .
ANNALS OF INTERNAL MEDICINE, 1987, 106 (06) :817-822
[2]   THE NEUROPSYCHIATRIC EFFECTS OF TREATMENT WITH INTERLEUKIN-2 AND LYMPHOKINE-ACTIVATED KILLER-CELLS [J].
DENICOFF, KD ;
RUBINOW, DR ;
PAPA, MZ ;
SIMPSON, C ;
SEIPP, CA ;
LOTZE, MT ;
CHANG, AE ;
ROSENSTEIN, D ;
ROSENBERG, SA .
ANNALS OF INTERNAL MEDICINE, 1987, 107 (03) :293-300
[3]  
DUTCHER JP, 1987, P ASCO, V6, pA970
[4]  
ETTINGHAUSEN SE, 1987, BLOOD, V69, P1654
[5]  
ETTINGHAUSEN SE, 1985, J IMMUNOL, V135, P3623
[6]  
FISHER RI, 1987, P AM SOC CLIN ONCOL, V6, pA959
[7]   LONG-TERM CULTURE OF TUMOR-SPECIFIC CYTOTOXIC T-CELLS [J].
GILLIS, S ;
SMITH, KA .
NATURE, 1977, 268 (5616) :154-156
[8]   LYMPHOKINE-ACTIVATED KILLER CELL PHENOMENON - LYSIS OF NATURAL KILLER-RESISTANT FRESH SOLID TUMOR-CELLS BY INTERLEUKIN 2-ACTIVATED AUTOLOGOUS HUMAN PERIPHERAL-BLOOD LYMPHOCYTES [J].
GRIMM, EA ;
MAZUMDER, A ;
ZHANG, HZ ;
ROSENBERG, SA .
JOURNAL OF EXPERIMENTAL MEDICINE, 1982, 155 (06) :1823-1841
[9]  
HANK JA, IN PRESS CANCER RES
[10]   INTERLEUKIN-2 INDUCES ANTIGEN-REACTIVE T-CELL LINES TO SECRETE BCGF-I [J].
HOWARD, M ;
MATIS, L ;
MALEK, TR ;
SHEVACH, E ;
KELL, W ;
COHEN, D ;
NAKANISHI, K ;
PAUL, WE .
JOURNAL OF EXPERIMENTAL MEDICINE, 1983, 158 (06) :2024-2039